{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-25-000005","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.755373+00:00","generated_at":"2026-05-28T00:46:43.953515+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Intuitive Q4 rev $2.41B (+25% YoY), procedures +18%; guides 2025 procedure growth 13-16%","bullets":["Q4 preliminary revenue $2.41B, up 25% YoY; full-year 2024 revenue $8.35B, up 17%.","Q4 da Vinci procedures grew ~18% YoY; full-year procedures up ~17% to 2,683,000.","493 da Vinci systems placed in Q4 (174 da Vinci 5), up 19% YoY; 1,526 in 2024, up 11%.","2025 procedure growth guidance of 13-16% vs 2024.","Q4 instruments & accessories revenue $1.41B (+23%), systems revenue $655M (+36%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-25-000005","json":"https://secwatch.observer/filing/0001035267-25-000005.json","markdown":"https://secwatch.observer/filing/0001035267-25-000005.md","text":"https://secwatch.observer/filing/0001035267-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000005/0001035267-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526725000005/isrg-20250115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:46:43.953515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}